下一个会是$Depomed(DEPO)$ 吗?查看全文
ddzan2015-12-05 01:17
“MRK is interested in RLYP”——放飞了ZSPH,这次要睁大眼睛盯了
$RELYPSA(RLYP)$ $ZS Pharm(ZSPH)$查看全文
ddzan2015-11-06 15:06
ZSPH AstraZeneca to acquire ZS Pharma for $90/sh, or $2.7B ($63.31)
真心卖飞了……
$ZS Pharm(ZSPH)$查看全文
ddzan2015-10-22 20:55
Veltassa has a boxed warning because it binds many other orally administered drugs, which could decrease their absorption and reduce their effects.
The warning recommends taking it and any other orally administered medication at least six hours apart.
The drug must be d...查看全文
ddzan2015-10-22 20:48
FDA approves Veltassa, but with boxed warning $ZS Pharm(ZSPH)$ $RELYPSA(RLYP)$查看全文
$ZS Pharm(ZSPH)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0000902664-16-005729 Size: 42 KB 网页链接
$ZS Pharm(ZSPH)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001193125-16-455392 Size: 38 KB 网页链接
$ZS Pharm(ZSPH)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2015-12-28 AccNo: 0000950103-15-009748 Size: 9 KB 网页链接
$ZS Pharm(ZSPH)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2015-12-21 AccNo: 0000950103-15-009626 Size: 22 KB 网页链接
$ZS Pharm(ZSPH)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2015-12-21 AccNo: 0000950103-15-009625 Size: 132 KB 网页链接
$ZS Pharm(ZSPH)$ SC 14D9/A [Amend] - Solicitation, recommendation statements Filed: 2015-12-18 AccNo: 0001193125-15-407842 Size: 13 KB 网页链接
$ZS Pharm(ZSPH)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2015-12-17 AccNo: 0000950103-15-009581 Size: 64 KB 网页链接
$ZS Pharm(ZSPH)$ SC 14D9/A [Amend] - Solicitation, recommendation statements Filed: 2015-12-17 AccNo: 0001193125-15-405550 Size: 15 KB 网页链接
$ZS Pharm(ZSPH)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-12-17 AccNo: 0001193125-15-405946 Size: 15 KB 网页链接
$ZS Pharm(ZSPH)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2015-12-17 AccNo: 0001193125-15-405941 Size: 15 KB 网页链接